HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bobe, G. Articles by Beitz, D. C. Search for Related Content PubMed PubMed Citation Articles by Bobe, G. Articles by Beitz, D. C.

Potential Treatment of Fatty Liver with 14-Day Subcutaneous Injections of Glucagon¹

Nutritional Physiology Group, Department of Animal Science, Iowa State University, Ames 50011-3150

Corresponding author: D. C. Beitz; e-mail: dcbeitz{at}iastate.edu.

Fatty liver is a major metabolic disease of dairy cows in early lactation that can be treated with 14-d continuous, intravenous infusions of 10 mg/d of glucagon. The objective was to test whether similar effects can be obtained with 14-d subcutaneous 7.5- or 15-mg daily dosages of glucagon beginning at d 8 postpartum. Multiparous Holstein cows (n = 32) were grouped on the basis of their liver triacylglycerol concentration at d 8 postpartum into "normal" (n = 8; triacylglycerol <1% liver wet wt) and "susceptible" (n = 24; triacylglycerol > 1% liver wet wt) cows. Susceptible cows were assigned randomly to three groups and beginning at d 8 postpartum received 0, 2.5, or 5 mg of glucagon in 60 ml of saline by subcutaneous injections every 8 h for 14 d. Beginning at d 8 postpartum, normal cows received 60 ml of saline by subcutaneous injections every 8 h for 14 d. Both dosages of glucagon increased concentrations of plasma glucose and insulin and decreased concentrations of plasma nonesterfied fatty acids. Glucagon injections of 15 mg/d decreased concentrations of liver triacylglycerol in cows older than 3.5 yr, but not in younger multiparous cows. Our results document that subcutaneous injections of glucagon have the potential to decrease the degree of fatty liver in older dairy cows in early lactation.

Key Words: dairy cow • early lactation • fatty liver • glucagon

Abbreviation key: AMN = -amino nitrogen, TAG = triacylglycerol

This article has been cited by other articles:

				R. A. Nafikov, B. N. Ametaj, G. Bobe, K. J. Koehler, J. W. Young, and D. C. Beitz Prevention of Fatty Liver in Transition Dairy Cows by Subcutaneous Injections of Glucagon J Dairy Sci, May 1, 2006; 89(5): 1533 - 1545. [Abstract] [Full Text] [PDF]

				E. L. Williams, S. M. Rodriguez, D. C. Beitz, and S. S. Donkin Effects of Short-Term Glucagon Administration on Gluconeogenic Enzymes in the Liver of Midlactation Dairy Cows J Dairy Sci, February 1, 2006; 89(2): 693 - 703. [Abstract] [Full Text] [PDF]

				G. Bobe, J. W. Young, and D. C. Beitz Invited Review: Pathology, Etiology, Prevention, and Treatment of Fatty Liver in Dairy Cows J Dairy Sci, October 1, 2004; 87(10): 3105 - 3124. [Abstract] [Full Text] [PDF]